News & Updates

Updates, press releases, and news on our work on GB-13.

Targepeutics Announces Phase I SBIR Grant to Support GB-13 Development

Targepeutics announces a Phase I Small Business Innovation Research (SBIR) grant awarded to Dr Randy Schrecengost as Primary Investigator to support preliminary data demonstrating that GB13 can specifically target IL13Rα2-positive…

Read More

GB13 Clinical Trial Presented at International Conference

A poster presentation, entitled LOCO-REGIONAL INFUSION OF GB-13 (IL13.E13K-PE4E) AS A POTENTIALLY PROMISING TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA is presented at the SNO 2022 Annual Clinical Trials and Brain Metastases…

Read More